LAS VEGAS — The Omni surgical system reduced IOP through 3 months in patients with open-angle glaucoma, according to research presented at the American Society of Cataract and Refractive Surgery meeting.
Brian Flowers, MD, presented 3-month interim data from the ORION study exploring the efficacy and safety of the Omni surgical system (Sight Sciences) in pseudophakic eyes with mild to moderate open-angle glaucoma. Patients did not have a history of glaucoma surgery except for implantation of iStent or iStent inject (Glaukos).
In a multicenter study comprising 54 pseudophakic eyes,